SPECIALISTS FROM THE CUBAN CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY VISITS MONGOLIA
Mr.Eulogio Pimentel, General Director of the Center for Genetic Engineering and Biotechnology of Cuba, Mr.Manuel Rafael Raices Perez-Castaneda, Business executive and project analyst in biotechnology, Mr.Abel Hernandez Velazquez, Head of plant biotechnology direction, are paying a visit to Mongolia on 12-17 March, 2017.
During their stay in Mongolia, the specialists from Cuba have visited the National Research Center for Zoonotic Diseases, Institute of Animal Health, the First Central Hospital of Mongolia, National Research Center of Infectious Diseases and “Bio-Combinat” SOE at Songino. Also the Cuban specialists have exchanged views and experiences with representatives of the “Hope” Cancer-Free Mongolia National Foundation, Mongol Emimpex Concern, “IVCO” Co.,Ltd, Monos Pharma, Songdo Hospital and Monfarm Trade.
On March 16th 2017, Mrs. Tsogtsetseg Ayush, Minister of Health, met with the Cuban specialists and among other issues, has expressed her belief that cooperation between the two countries in health sector will significantly contribute to introduction of new advanced technology, treatment and development of biotechnological industry in Mongolia. At the same day, the Letter of Intent for cooperation in the field of cardiovascular disease, hepatitis B, diabetes foot ulcer therapy, hemorrhoids and lung cancer treatments between the First Central Hospital of Mongolia and the Center for Genetic Engineering and Biotechnology of Cuba was signed.
During the official visit of H.E. Mr. Elbegdorj Tsakhia, President of Mongolia, to the Republic of Cuba in September 2016, the President have visited the Genetic Engineering and Biotechnology Center and invited specialists of the center to visit Mongolia. The visit of the Cuban specialists is one of the follow-ups of the President’s visit to Cuba.
With 31 subsidiaries and 78 pharmaceutical manufacturers, and employing over 22 thousand workers, the Cuban Center for Genetic Engineering and Biotechnology is among the five largest genetic engineering and biotechnological centers in the world. The company exports 45 types of medicines and vaccines to more than 50 countries and implements health programs in 23 different countries around the globe.